Home About Us Products Acid Bromide Aliphatic Amine Hydrochloride Aliphatic Bromide Aliphatic Esters Aromatic Bromide Dibromo Alkane Inorganic Bromoide Lithium Compounds Others Quality Policy Career Contact 0 Home About Us Products Acid Bromide Aliphatic Amine Hydrochloride Aliphatic Bromide Aliphatic Esters Aromatic Bromide Dibromo Alkane Inorganic Bromoide Lithium Compounds Others Quality Policy Career Contact 0 Products Back to Shop Ethylene Di Bromide |106-93-4 | (CH2Br)2 | 1,2-dibromoethane Category: Dibromo Alkane Tags: 1 , 1.2-dibromoethane , 106-93-4 , 1N41638RNO , 2 , 2-Dibromaethan , 2-Dibromaethan [German] , 2-dibromo ethane , 2-DIBROMO TETRADEUTERO ETHANE , 2-dibromo- , 2-Dibromoetano , 2-Dibromoetano [Italian] , 2-Dibromoethane , 2-Dibromoethane solution , 2-Dibromoethane(Ethylene bromide) , 2-Dibromomethane , 2-Dibroomethaan , 2-Dibroomethaan [Dutch] , 2-Ethylene dibromide , 20571-EP2270008A1 , 20571-EP2272516A2 , 20571-EP2275102A1 , 20571-EP2275411A2 , 20571-EP2277878A1 , 20571-EP2280012A2 , 20571-EP2284159A1 , 20571-EP2287153A1 , 20571-EP2289891A2 , 20571-EP2292617A1 , 20571-EP2298776A1 , 20571-EP2305254A1 , 20571-EP2305651A1 , 20571-EP2308838A1 , 20571-EP2308854A1 , 20571-EP2308873A1 , 20571-EP2311824A1 , 20571-EP2314585A1 , 240656_ALDRICH , 2dibromoethane , 349 , 3B4-2837 , 4-01-00-00158 (Beilstein Handbook Reference) , 4-triazol-3(4H)-one , 40171_SUPELCO , 48880U_SUPELCO , 5-amino-2H-1 , 56729-21-6 , 625084-37-9 , 6737-EP1441224A2 , 6737-EP2298756A1 , A16171 , Aadibroom , AC1L1PO3 , AC1Q27RT , ACMC-1BNI8 , Aethylenbromid , Aethylenbromid [German] , AI3-15349 , AKOS000118755 , alpha , AN-5045 , ANW-15461 , AR-1B5719 , BB_SC-7189 , BBL012210 , beta-Dibromoethane , BIDD:ER0281 , BP-13439 , BRN 0605266 , Bromofume , Bromuro di etile , Bromuro di etile [Italian] , C11088 , CAS-106-93-4 , Caswell No
formal analysis, A.F.A., K.J., B.B., S.K., P.W., M.S
PMID: 42289375 Exp Cell Res2025 Sep 1;452(1):114744
One treatment per week for twenty-three consecutive weeks decreased pain and positively influenced components relating to chronic illness and functional health capacity
L- 30
In a balanced response, this acute inflammation clears pathogens and facilitates the transition to the proliferative phase of wound healing
